MedPath

AMPROLOX 20% Powder

Registration Number: MAL13110048HA

Approved
Approval ID

bdf005173700d816

Registration Number

MAL13110048HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types2 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (2)

500.00 gmAvailable
Package Size: 500.00 gm
Status: NPRA Approved
100.00 gmAvailable
Package Size: 100.00 gm
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

AMPROLIUM HYDROCHLORIDEActive
Monograph: amprolium hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMPROLOX 20% Powder - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform